This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Development Co. Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anat Bahat: Innovator in SPT5 Inhibitors
Introduction
Anat Bahat is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of SPT5 inhibitors. His work has implications for various therapeutic applications.
Latest Patents
Anat Bahat holds a patent titled "SPT5 INHIBITORS AND USES THEREOF." This patent represents his innovative approach to targeting specific biological pathways, which could lead to advancements in medical treatments.
Career Highlights
Anat Bahat is associated with Yeda Research and Development Co. Ltd., where he has been instrumental in driving research initiatives. His expertise in biotechnology has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Anat collaborates with Rivka Dikstein, a fellow researcher. Their partnership exemplifies the collaborative spirit in scientific research, contributing to the advancement of their field.
Conclusion
Anat Bahat's work in developing SPT5 inhibitors showcases his innovative spirit and dedication to advancing biotechnology. His contributions are paving the way for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile